Loading
Yanuki
KEYWORD TOPIC
Artelo Biosciences' ART12.11 Shows Promise in Treating Stress-Induced Depression | Artelo Biosciences' ART12.11 Shows Promise in Treating Stress-Induced Depression

Health / Mental Health

Artelo Biosciences' ART12.11 Shows Promise in Treating Stress-Induced Depression

Artelo Biosciences (Nasdaq: ARTL) has announced promising preclinical results for its drug candidate ART12.11, a CBD:TMP cocrystal, in treating stress-induced depression. The data, presented at the 35th Annual International Cannabinoid Rese...

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model
Artelo Biosciences' ART12.11 Shows Promise in Treating Stress-Induced Depression Image via Yahoo Finance
TOPIC artl stock